PrecisionBiotics Group Limited acquired by Novozymes
Novozymes acquired PrecisionBiotics Group Limited, a Cork, Ireland supplements brand, on Jun 25, 2020.
Preliminary: The transaction value is not yet independently verified.
Transaction summary
- Target
- PrecisionBiotics Group Limited
- Acquirer
- Novozymes
- Announced
- 2020-06-25
- Geography
- Cork, Ireland
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- 100%
- First added
- 2026-10-31
- Latest update
- 2026-10-31
Value and multiples
100% enterprise value
DKK 600M
Unverified
100% enterprise value | DKK
Basis: Estimated
Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.
Approx. $90.2M USD using FX date 2020-06-25 at 0.1503 DKK/USD.
EV / revenue
6x
Period: FY2019
Basis: Public source
EV / EBITDA
-
EBITDA basis not stated
Basis: Public source
Basis
- Approximate value: DKK 600m enterprise value. Multiples use revenue of DKK 100m (FY2019).
Source summary
Novozymes acquires PrecisionBiotics Group to advance its business within human health
EstimatedNovozymes has acquired 100% of the equity in PrecisionBiotics Group Limited for an amount of DKK 600 million
Open sourceContinue your research
Related transaction comps
Jennewein Biotechnologie GmbH acquired by Chr. Hansen Holding A/S
2020-09-22 · Confirmed
View transaction → consumer healthVitabiotics acquired by Bain Capital
2026-07-24 · Confirmed
View transaction → consumer healthOpella acquired by Clayton, Dubilier & Rice
2024-10-21 · Confirmed
View transaction → consumer healthOnnit Labs, Inc. acquired by Unilever
2021-04-26 · Estimated
View transaction →